Former Emisphere investors sue following sale to Novo Nordisk
The USD 1.8bn price does not reflect the value of Emisphere, according to former Emisphere shareholders, who have sued MHR Fund Management.
BY MAIKEN REIMER RØNNEBERG, TRANSLATED BY NIELSINE NIELSEN
Last year, Novo Nordisk bought US company Emisphere Technologies for USD 1.8bn. Former investors in Emisphere are now suing the company's largest shareholder, MHR Fund Management, according to Fierce Pharma.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novo Holdings plans to enter China
For subscribers
Novo Holdings acquires diagnostics company for USD 564m
For subscribers
Danish companies: A minimum tax rate has advantages
For subscribers
